MMRGlobal at Verizon and Alcatel-Lucent Healthcare and Life

MMRGlobal at Verizon and Alcatel-Lucent Healthcare and Life Science
Symposium in Las Vegas Today 
LOS ANGELES, CA -- (Marketwire) -- 11/13/12 --  MMRGlobal, Inc.
(OTCBB: MMRF) CEO Robert H. Lorsch is attending the Verizon and
Alcatel-Lucent Annual Healthcare and Life Science Symposium in Las
Vegas today. The event specifically addresses advancements in
wireless technology for the healthcare industry which is a primary
focus of MMR ( The Company has been
invited by Alcatel-Lucent to participate in discussions regarding the
sale and licensing of its patented Personal Health Record (PHR),
which includes a telemedicine portal for use by hospitals,
physicians, carriers, payers, and other healthcare professionals. MMR
currently holds four U.S. patents with more than 180 claims for
health IT products and services and also has patents that are issued,
pending and/or applied for in more than 13 countries of commercial
interest around the world. 
Using the Verizon and Alcatel-Lucent mobile healthcare platforms and
services for telemedicine, the patented Personal
Health Record can help physicians, caretakers and family members
better monitor patients. "I have had a long relationship with Verizon
Wireless, going back to the early days of AirTouch," said Lorsch. "We
also hold a significant patent portfolio pertaining to Personal
Health Records and other eHealth products and services that create
both a barrier to competitive entry and generating revenue to the
Company from licensing activities." 
The re-election of President Obama means healthcare reform is here to
stay. This benefits companies like MMRGlobal that enable patients to
have timely online access to their personal health information as
mandated through Meaningful Use under the HITECH Act by 2014. And
with tens of millions of U.S. citizens becoming newly insured under
the Affordable Care Act, and therefore consumers of healthcare,
greater patient engagement will be essential to manage care and costs
by providing patients with a PHR.  
About MMRGlobal 
MMRGlobal, Inc., through its wholly-owned operating subsidiary,
MyMedicalRecords, Inc., provides secure and easy-to-use online
Personal Health Records ("PHRs") and electronic safe 
deposit box
storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, and
professional organizations and affinity groups. The MyMedicalRecords
PHR enables individuals and families to access their medical records
and other important documents, such as birth certificates, passports,
insurance policies and wills, anytime from anywhere using the
Internet. MyMedicalRecords is built on proprietary, patented
technologies to allow documents, images and voicemail messages to be
transmitted and stored in the system using a variety of methods,
including fax, phone, or file upload without relying on any specific
electronic medical record platform to populate a user's account. The
Company's professional offering, MMRPro, is designed to give
physicians' offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients in real
time through an integrated patient portal. Through its merger with
Favrille, Inc. in January 2009, the Company acquired intellectual
property biotech assets that include anti-CD20 antibodies and data
and samples from its FavId(TM)/Specifid(TM) vaccine clinical trials
for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more
about MMRGlobal, Inc. visit View demos and video
tutorials of the Company's products and services at 
Forward-Looking Statements 
Statements in this press release that are not strictly historical in
nature, including future performance, expectations, beliefs,
intentions, estimates or projections, constitute "forward-looking
statements." Such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause
MMRGlobal, Inc.'s actual results to be materially different from
historical results or from any results expressed or implied by such
forward-looking statements. Some can be identified by the use of
words (and their derivations) such as "need," "possibility," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Factors that could cause
or contribute to such differences include, but are not limited to,
the risk our products and services are not adopted or viewed
favorably by consumers and the healthcare community, both in the U.S.
and internationally; risks related to the current uncertainty and
instability in financial and lending markets, including global
economic uncertainties; our ability to maintain, develop, monetize
and protect our patent portfolio for both the Company's health IT and
biotechnology intellectual property assets in the U.S. and
internationally product integration in physician practices and
hospitals; timing and volume of sales and installations; length of
sales cycles and the installation process; market acceptance of new
product introductions; ability to establish and maintain strategic
relationships; ability to identify and integrate acquisitions;
relationships with licensees; competitive product offerings and
promotions; changes in government laws and regulations including the
HITECH Act of 2009 and the Affordable Care Act of 2010, and future
changes in tax legislation and initiatives in the healthcare
industry, both in the U.S. and internationally; undetected errors in
our products; possibility of interruption at our data centers; risks
related to third party vendors; risks related to obtaining and
integrating third-party licensed technology; acceptance of the
Company's marketing and promotional campaigns; risks related to a
security breach by third parties; litigation matters; risks
associated with recruitment and retention of key personnel;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in the
Company's filings with the United States Securities and Exchange
Commission. MMRGlobal, Inc. is providing this information as of the
date of this release and, except as required by law, does not
undertake any obligation to update any forward-looking statements
contained in this release as a result of new information, future
events or otherwise.  
MMRGlobal Contact
Michael Selsman
Public Communications Co.
(310) 922-7033 
Press spacebar to pause and continue. Press esc to stop.